YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy

2016 ◽  
Vol 15 (6) ◽  
pp. 812-821 ◽  
Author(s):  
Katarína Gyurászová ◽  
Jaromír Mikeš ◽  
Andrea Halaburková ◽  
Rastislav Jendželovský ◽  
Peter Fedoročko

Here we show for the first time that the repression of survivin expression by YM155 is effective in sensitizing cancer cells to HY-PDT, as measured by the decrease in cell viability and induction of apoptosis.

2021 ◽  
pp. 112637
Author(s):  
Aderonke Ajayi-Smith ◽  
Pauline van der Watt ◽  
Nonkululeko Mkwanazi ◽  
Sarah Carden ◽  
John O. Trent ◽  
...  

2015 ◽  
Vol 35 (6) ◽  
Author(s):  
Lijs Beke ◽  
Cenk Kig ◽  
Joannes T. M. Linders ◽  
Shannah Boens ◽  
An Boeckx ◽  
...  

Protein kinase MELK has oncogenic properties and is highly overexpressed in some tumors. In the present study, we show that a novel MELK inhibitor causes both the inhibition and degradation of MELK, culminating in replication stress and a senescence phenotype.


RNA Biology ◽  
2021 ◽  
pp. 1-18
Author(s):  
Nadav Wallis ◽  
Froma Oberman ◽  
Khriesto Shurrush ◽  
Nicolas Germain ◽  
Gila Greenwald ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document